SMTI 37.28 (+0.89%)
US79957L1008Healthcare Providers & ServicesMedical Care Facilities

Sanara MedTech (SMTI) Stock Highlights

37.28 | +0.89%
2024-11-21 05:05:11
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel.

Statistics

Range Today
36.38 38.22
Volume Today 62.1K
Range 1 Year
26 43.25
Volume 1 Year 4.81M
Range 3 Year
17.41 50.18
Volume 3 Year 13.44M
Range 10 Year
2 75
Volume 10 Year 22.05M

Highlights

Market Capitalization 308.24M (small)
Floating Shares 3.54M
Current Price 37.28
Price To Earnings -41.89
Price To Revenue 4.39
Price To Book 7.39
Earnings Per Share -0.8
Payout Ratio 0%

Performance

Latest +0.89%
1 Month +11.95%
3 Months +15.6%
6 Months +19.18%
1 Year +12.22%
3 Years +23.24%
5 Years +253.36%
10 Years +432.57%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.